We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 135 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/6/2021 13:50 | dave4545 7 Jun '21 - 13:37 - 3105 of 3109 Does NSCI hold 100% of this ? __________________ 5.75% of PDSB | kalkaar | |
07/6/2021 13:49 | PDSB presentation is after UK close PDSB news this morning they are going into Russell Index which should cause some technical buying | the stigologist | |
07/6/2021 13:47 | Market shaking a few into selling....watch it turn again this afternoon! | chesty1 | |
07/6/2021 13:44 | Would it not be easier just to answer my question. If they hold 100% then it's massive, if they hold 5-10% then it's good. Hell of a difference. | dave4545 | |
07/6/2021 13:42 | You can always rely on Dave the rave to put a dampener on things. Dave why have you blocked me from Threads that you create? | anti corruption | |
07/6/2021 13:37 | Does NSCI hold 100% of this ? Just because people used to get all excited about PDSB not knowing they only have a small % of them. | dave4545 | |
07/6/2021 13:24 | My 2500 buys showing as sells | prince7652 | |
07/6/2021 13:19 | Does anyone know the time of pdsb presentation? | blakieboy7 | |
07/6/2021 13:17 | Proaxsis in the shop window now NSCI could literally get the test validated then flip Proaxsis to the highest bidder in the same field with the AZN deal signed how much would that be worth? big value inflection point today for sure.. | kalkaar | |
07/6/2021 13:11 | Bill, today is presentation day for $PDSB's versamune - let's just it's likely to be price sensitive lol | kalkaar | |
07/6/2021 13:09 | TBH I can't see what I am missing here. PDBS pres value $15m so this new deal with AZ pres worth less than £10M?? WTF.Why did the share price not double immediately after this RNS? Still I am happy as I bought.Looking forward to this afternoon.Anyone think that the PDBS share price could also rise today? | billthebank | |
07/6/2021 13:03 | Hold it around £1.25p then it will fly again later on today! | chesty1 | |
07/6/2021 12:58 | Nice Post Stig | billthebank | |
07/6/2021 12:56 | easily 100% I reckon . | manual dexterity | |
07/6/2021 12:56 | good post Stig.. you have consistently posted the valuation argument and attractions for a while here and on twitter.. | kalkaar | |
07/6/2021 12:55 | next wave to +100% | ak62 | |
07/6/2021 12:51 | Still way undervalued. | investordave | |
07/6/2021 12:50 | I think the market is finally waking up to today's news! | chesty1 | |
07/6/2021 12:48 | it be wow 160p to buy soon :-) | ak62 | |
07/6/2021 12:46 | Wow 128 to buy | blakieboy7 | |
07/6/2021 12:46 | Today's news from NSCI re marketing an Astra Zeneca SARS-COV2 test is exciting but should be just the start ProAxsis the portfolio Company involved in this deal is 95% owned by NSCI but only accounted for £3.5m of the c.£30m NAV NSCI Share Price @ 100p with 15m shares outstanding gives a Market Cap of £15m vs NAV of 200p+ (£30m+) ! So despite this morning's 50% rise you can still get into NSCI 'cheap' Furthermore NSCI's two big investments PDSB and Glycotest are both due to report potential value inflection point news in next 1 month PDS Biotech (NASDAQ : PDSB) has 3 Presentations scheduled in next 2 weeks 1. June 7th at ASCO Cancer Research Conference 2. June 8th Conf Call with analysts re ASCO Presentation 3. June 16th Investor Day featuring presentations from 3 US Government Scientists ! Glycotest is a Liver Cancer test currently in clinical trials of which NSCI own 50% with 40% owned by Chinese conglomerate Fosun (also owners of Wolves, Thomas Cook, Chinese partners for Pfizer/BioNTech vaccine). Liver Cancer test market is a $1bn+ opportunity. 2 Principals (CEO and 1 other shareholder) own 60% of NSCI so it's very tightly held How many Biotechs do you know where 3 US Government Scientists from the National Cancer Institute present on behalf of your collaboration ?! | the stigologist | |
07/6/2021 12:45 | offering 1.20 to sell no quote to buy | ak62 | |
07/6/2021 12:44 | Sticking with my original 1.40 at close today, see this hitting £2 in the next 2 trading sessions.... | samsung2020 | |
07/6/2021 12:44 | +100% on the card | ak62 | |
07/6/2021 12:42 | the only buying i can see coming from the US would be PI's looking for a route into PDSB.. | kalkaar |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions